Stuart J. Blakemore

847 total citations
9 papers, 155 citations indexed

About

Stuart J. Blakemore is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Stuart J. Blakemore has authored 9 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 3 papers in Molecular Biology. Recurrent topics in Stuart J. Blakemore's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cell death mechanisms and regulation (2 papers). Stuart J. Blakemore is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cell death mechanisms and regulation (2 papers). Stuart J. Blakemore collaborates with scholars based in United Kingdom, Germany and United States. Stuart J. Blakemore's co-authors include Graham Packham, Mark S. Cragg, Jonathan C. Strefford, Francesco Forconi, Marta Larráyoz, Matthew Rose‐Zerilli, Renata Walewska, Minoru Yoshida, Andrew Duncombe and David Oscier and has published in prestigious journals such as Clinical Cancer Research, Cell Death and Differentiation and Leukemia.

In The Last Decade

Stuart J. Blakemore

9 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart J. Blakemore United Kingdom 7 97 53 42 28 25 9 155
Sven Turkalj United Kingdom 5 47 0.5× 40 0.8× 39 0.9× 31 1.1× 31 1.2× 9 114
Sandra Graß Germany 6 55 0.6× 61 1.2× 38 0.9× 44 1.6× 22 0.9× 11 152
Ernesto Gargiulo Luxembourg 7 72 0.7× 40 0.8× 51 1.2× 22 0.8× 24 1.0× 13 123
Stefanie Kreutmair Germany 9 88 0.9× 17 0.3× 40 1.0× 15 0.5× 49 2.0× 21 173
Nur Hezrin Shahrin Australia 5 52 0.5× 39 0.7× 32 0.8× 11 0.4× 13 0.5× 16 130
Vijitha Sathiaseelan United Kingdom 5 134 1.4× 54 1.0× 24 0.6× 23 0.8× 22 0.9× 7 198
Olga Stehlíková Czechia 7 51 0.5× 56 1.1× 52 1.2× 40 1.4× 22 0.9× 14 146
Miguel Quijada‐Álamo Spain 9 80 0.8× 124 2.3× 66 1.6× 68 2.4× 67 2.7× 17 191
María Abáigar Spain 7 82 0.8× 44 0.8× 12 0.3× 19 0.7× 25 1.0× 16 150
Corinna Albers Germany 7 92 0.9× 42 0.8× 23 0.5× 8 0.3× 25 1.0× 13 171

Countries citing papers authored by Stuart J. Blakemore

Since Specialization
Citations

This map shows the geographic impact of Stuart J. Blakemore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Blakemore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Blakemore more than expected).

Fields of papers citing papers by Stuart J. Blakemore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart J. Blakemore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Blakemore. The network helps show where Stuart J. Blakemore may publish in the future.

Co-authorship network of co-authors of Stuart J. Blakemore

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart J. Blakemore. A scholar is included among the top collaborators of Stuart J. Blakemore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart J. Blakemore. Stuart J. Blakemore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Neumann, Lars, Stuart J. Blakemore, J. Raúl Alvarez‐Idaboy, et al.. (2023). Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ. Communications Biology. 6(1). 603–603. 1 indexed citations
2.
Meyer, Anja, Ruth Esser, Stuart J. Blakemore, et al.. (2021). Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis. Journal of Autoimmunity. 124. 102726–102726. 17 indexed citations
3.
Else, Monica, Stuart J. Blakemore, Jonathan C. Strefford, & Daniel Catovsky. (2021). The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial. Leukemia. 35(9). 2563–2569. 7 indexed citations
4.
Blakemore, Stuart J., Elena Izquierdo, Daniela Vorholt, et al.. (2020). Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2. Cancers. 12(8). 2303–2303. 11 indexed citations
5.
Blakemore, Stuart J., Ruth Clifford, Pavlos Antoniou, et al.. (2017). The contribution of gene mutations to long-term clinical outcomes: data from the randomised UK LRF CLL4 trial. ePrints Soton (University of Southampton). 2 indexed citations
6.
Pandzic, Tatjana, Jimmy Larsson, Liqun He, et al.. (2016). Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(24). 6217–6227. 14 indexed citations
7.
Carter, Matthew, Kerry L. Cox, Stuart J. Blakemore, et al.. (2016). PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosis. Leukemia. 31(6). 1423–1433. 11 indexed citations
8.
Larráyoz, Marta, Stuart J. Blakemore, Rachel Dobson, et al.. (2015). The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1. Leukemia. 30(2). 351–360. 83 indexed citations
9.
Carter, Matthew, Kerry L. Cox, Stuart J. Blakemore, et al.. (2015). BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma. Cell Death and Differentiation. 23(2). 303–312. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Turkalj Breakdown of academic impact, for papers by Sandra Graß Breakdown of academic impact, for papers by Ernesto Gargiulo Breakdown of academic impact, for papers by Stefanie Kreutmair Breakdown of academic impact, for papers by Nur Hezrin Shahrin Breakdown of academic impact, for papers by Vijitha Sathiaseelan Breakdown of academic impact, for papers by Olga Stehlíková Breakdown of academic impact, for papers by Miguel Quijada‐Álamo Breakdown of academic impact, for papers by María Abáigar Breakdown of academic impact, for papers by Corinna Albers
Rankless by CCL
2026